TrialClinical and translational science2023

Phase I crossover study of DNA-protein kinase inhibitor peposertib in healthy volunteers: Effect of food and pharmacokinetics of an oral suspension.

Andreas Becker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.